Rare diseases
Investigational molecules
Locations
12830 El Camino Real Suite 400, 92130-2976, United States
The sponsor maintains a concentrated focus on addressing complex neuropsychiatric conditions associated with neurodegenerative diseases. Research efforts center on therapeutic interventions for Parkinson's disease psychosis, a debilitating complication affecting patients with progressive motor disorders. The organization investigates treatment approaches for hallucinations and delusions that emerge in patients with established Parkinson's disease, seeking to improve both psychiatric symptoms and overall quality of life.
The therapeutic strategy emphasizes managing the psychiatric manifestations that frequently accompany motor symptoms in neurodegenerative conditions, representing a specialized area of expertise in addressing the intersection between movement disorders and psychiatric symptomatology.
Acadia Pharmaceuticals Inc. runs clinical trials in conditions such as Dementia with Lewy bodies, Dementia Alzheimer's type, Hyperphagia, Autism spectrum disorder, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BulgariaBulgariaBulgaria
FranceFrance
BelgiumBulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
